Target (CBDY) EBIAT (2013 - 2026)
Target (CBDY) reported EBIAT of -$550356.0 for Q1 2026, down 408.59% year-over-year from $178347.8 in Q1 2025, and little changed quarter-over-quarter from -$552307.0 in Q4 2025.
Target (CBDY) EBIAT (2013 - 2026) Analysis & Trends
Target (CBDY) has 14 years of EBIAT data on file, last reported at -$550356.0 in Q1 2026.
- EBIAT for Q1 2026 came in at -$550356.0, down 408.59% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.8 million (down 834.06% YoY), and the FY2025 annual result was -$1.4 million, down 947.13% from the prior year.
- EBIAT was little changed at -$550356.0 in Q1 2026 per CBDY's latest filing, from -$552307.0 in the prior quarter.
- Over five years, EBIAT peaked at $963816.0 in Q2 2023 and troughed at -$745709.0 in Q1 2023.
- A 5-year average of -$108265.8 and a median of -$193168.0 in 2024 frame the typical range for EBIAT.
- On a YoY basis, EBIAT climbed as much as 359.8% in 2023 and fell as far as 908.69% in 2023.
- A 5-year view of EBIAT shows it stood at $217006.2 in 2022, then tumbled by 185.23% to -$184965.0 in 2023, then soared by 216.76% to $215958.0 in 2024, then tumbled by 355.75% to -$552307.0 in 2025, then climbed by 0.35% to -$550356.0 in 2026.
- Business Quant data shows CBDY's EBIAT at -$550356.0 in Q1 2026, -$552307.0 in Q4 2025, and -$479392.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 369.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 601.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 274.90 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -1.36 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 197.90 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 57.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 16.20 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 118.42 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -92.12 Mn |
| 10 | Target | - | - | 191,787.00 | -550,356.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -550,356.00 |
| Dec 31, 2025 | -552,307.00 |
| Sep 30, 2025 | -479,392.00 |
| Jun 30, 2025 | -219,770.00 |
| Mar 31, 2025 | -108,213.00 |
| Dec 31, 2024 | 215,958.00 |
| Sep 30, 2024 | -528,950.00 |
| Jun 30, 2024 | 666,664.00 |
| Mar 31, 2024 | -193,168.00 |
| Dec 31, 2023 | -184,965.00 |
| Sep 30, 2023 | -356,812.00 |
| Jun 30, 2023 | 963,816.00 |
| Mar 31, 2023 | -745,709.00 |
| Dec 31, 2022 | 217,006.16 |
| Sep 30, 2022 | -286,149.00 |
| Jun 30, 2022 | 209,616.61 |
| Mar 31, 2022 | 92,211.52 |
| Dec 31, 2021 | -392,386.41 |
| Sep 30, 2021 | -66,324.44 |
| Jun 30, 2021 | 827,015.00 |